Robert Fenton

Founder & CEO Qualio

Last Reviewed: September 18, 2026

Executive Summary

Robert Fenton is the founder and Chief Executive Officer of Qualio, a cloud quality management system for life sciences companies that he founded in Ireland in 2012 and now leads from San Francisco. The product addresses a constraint specific to regulated medicine: a company making a medical device or a drug cannot simply build a good product, it must document a controlled quality system proving how the product was built, and that documentation is itself subject to FDA, ISO, and GxP requirements. For small and mid-sized companies this has historically meant either paper binders or enterprise software priced and scoped for multinationals. Fenton knew the problem directly, having trained as a pharmacist and worked in quality and R&D roles at Pfizer and Leo Pharma before writing software for it.

Career Highlights

• Founded Qualio in Ireland in 2012 and leads it as CEO, now headquartered in San Francisco.
• Raised a $50 million Series B led by Tiger Global, bringing total funding to approximately $63 million.
• Recorded more than 260% year-over-year revenue growth during the company’s expansion.
• Built Qualio as an all-remote company from the first day, on a “local everywhere” model.
• Former community pharmacist, with quality and R&D roles at Pfizer and Leo Pharma.
• Represented Ireland at the 36th International Chemistry Olympiad in Kiel, Germany, in 2004.

Professional Journey

Fenton studied pharmacy for five years at University College Cork, having already represented Ireland at the 36th International Chemistry Olympiad in Kiel, Germany in 2004. He practiced as a community pharmacist before moving into industry, taking quality and research and development roles at Pfizer and Leo Pharma. That sequence gave him an unusually direct view of quality management: first as a practitioner dispensing regulated products, then inside the systems large pharmaceutical companies use to satisfy regulators.

The gap he identified was one of scale. Quality management for life sciences was well served at the top of the market, where multinationals could afford heavyweight enterprise systems and the consultants to configure them. Everyone below that tier — medical device startups, small biotechs, contract manufacturers — faced identical regulatory obligations with none of the resources, and typically managed their quality systems in documents, spreadsheets, and physical binders. The consequence was not merely inefficiency; an audit failure or a gap in a design history file can stop a product reaching patients.

Fenton founded Qualio in Ireland in 2012 to serve that underserved middle, building a cloud quality management system covering document control, training records, change management, supplier management, and audit readiness, designed to be implementable by a small company without a dedicated quality IT function. The company grew into the US market and is now headquartered in San Francisco, serving medical device, pharmaceutical, biotech, and contract manufacturing organizations working to GxP, FDA, and ISO standards.

Qualio has been notable for two structural choices. It was built as an all-remote company from day one, operating on what Fenton calls a “local everywhere” mentality rather than treating distributed work as a concession. And despite the San Francisco base and US investor backing, he has kept substantial hiring and investment in Ireland, with team members in Dublin, Cork, and Dingle. The company raised a $50 million Series B led by Tiger Global, bringing total funding to roughly $63 million, on the back of a period in which revenue grew more than 260% year over year.

Education

University College Cork

Pharmacy, five-year programme